NSCLC Grand Rounds – Salisbury, MD
This activity will cover the treatment and management of patients with non-small cell lung cancer (NSCLC).
12 events found.
NSCLC Grand Rounds
This activity will cover the treatment and management of patients with non-small cell lung cancer (NSCLC).
Ped-AD – Victoria, TX
Citizens Medical Center 2701 Hospital Drive, Victoria, TX, United StatesThis live activity will cover treating and managing atopic dermatitis in pediatric and adolescent patients.
TRK Fusion + Cancers – Bay Pines, FL
This program will review the use of CDK 4/6 inhibitors in the treatment of HR+/HER2-negative breast cancer and the management of treatment-related adverse events.
NSCLC Grand Rounds
This activity will cover the treatment and management of patients with non-small cell lung cancer (NSCLC).
Asthma Grand Rounds – Victoria, TX
This program will review current and emerging therapies for the management of moderate-to-severe uncontrolled asthma.
CDK 4/6 Inhibitors in HR+/HER2- Breast Cancer – Bronx, NY
NYC Health + Hospitals/Queens 82-68 164th Street Main-bldg, 5th Floor, Conference Room A540, Jamaica, NY, United StatesThis program will review the use of CDK 4/6 inhibitors in the treatment of HR+/HER2-negative breast cancer and the management of treatment-related adverse events.
Asthma Grand Rounds – South Miami, FL
This program will review current and emerging therapies for the management of moderate-to-severe uncontrolled asthma.
Hematologic Malignancies Grand Rounds (AML) – Steubenville, OH
This activity will cover the treatment and management of patients with AML.
Hemophilia A – Las Vegas, NV
MountainView Hospital Graduate Med Education 2880 North Tenaya Way, Suite 100, Las Vegas, NV, United StatesThis case-based live activity will cover the treatment and management of patients with hemophilia A
HER2-Positive Gastric Cancer
This program will review current and emerging therapies for the management of HER2-positive gastric cancer.
Asthma Grand Rounds – Chicago, IL
This program will review current and emerging therapies for the management of moderate-to-severe uncontrolled asthma.